Lobo Kevin
SEC CIK 1519419 · EDGAR
BoughtSold
Most active insiders at GEHC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | CULP H LAWRENCE JR | Dir | $5.00M | — |
| 2 | Lobo Kevin | Dir | $641.8K | — |
| 3 | Arduini Peter J | Pres, CEO, Dir | $249.8K | — |
| 4 | SACCARO JAMES | CFO | $200.6K | — |
| 5 | Jimenez Frank R | GC, Corp. Sec | $105.8K | — |
| 6 | Hochman Rodney F | Dir | $100.4K | — |
| 7 | Yang Watkin Phoebe L. | Dir | $63.0K | — |
| 8 | Stromberg William J | Dir | $61.7K | — |
| 9 | Estrampes Catherine | Chief Commer, Growth Off | — | — |
| 10 | Rackliffe Philip | CEO, AVS | — | — |
Transactions 38
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-26 18:44 | 2026-05-22 | GEHC | GE HealthCare | Lobo Kevin | Dir | P - Purchase | $64.18 | +10.0K | 14.4K | +229% | +$641.8K | |
| 2026-05-11 20:10 | 2026-05-07 | GEHC | GE HealthCare | Lobo Kevin | Dir | A - Grant | $0.00 | +3,586 | 4,363 | +462% | $0 | |
| D | 2026-03-24 | 2026-03-21 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | F - Tax | $335.67 | -26.5K | 222.2K | -11% | -$8.89M |
| D | 2026-03-24 | 2026-03-21 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | M - OptEx | $0.00 | +1,452 | 248.7K | +0.6% | $0 |
| 2026-03-17 | 2026-03-13 | GEHC | GE HealthCare | Lobo Kevin | Dir | A - Grant | $0.00 | +777 | 777 | New | $0 | |
| 2026-03-11 | 2026-03-09 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | A - Grant | $0.00 | +50.3K | 247.3K | +26% | $0 | |
| D | 2026-02-06 | 2026-02-06 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | M - OptEx | $96.64 | +207.0K | 329.4K | +169% | +$20.00M |
| D | 2026-02-06 | 2026-02-06 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | F - Tax | $362.42 | -132.4K | 196.9K | -40% | -$47.99M |
| 2025-12-05 | 2025-12-03 | PH | Parker Hannifin | Lobo Kevin | Dir | G - Gift | $0.00 | -2,048 | 5,824 | -26% | $0 | |
| 2025-10-24 | 2025-10-22 | PH | Parker Hannifin | Lobo Kevin | Dir | A - Grant | $0.00 | +258 | 7,872 | +3% | $0 | |
| A | 2025-04-25 | 2024-10-23 | PH | Parker Hannifin | Lobo Kevin | Dir | A - Grant | $0.00 | +299 | 11.1K | +3% | $0 |
| D | 2025-03-25 | 2025-03-21 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | M - OptEx | $0.00 | +1,085 | 145.6K | +0.8% | $0 |
| D | 2025-03-25 | 2025-03-21 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | F - Tax | $374.22 | -23.3K | 122.3K | -16% | -$8.73M |
| 2025-03-12 | 2025-03-10 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | A - Grant | $0.00 | +44.5K | 144.5K | +44% | $0 | |
| 2024-11-15 | 2024-11-13 | PH | Parker Hannifin | Lobo Kevin | Dir | G - Gift | $0.00 | -3,465 | 7,612 | -31% | $0 | |
| DM | 2024-11-08 | 2024-11-07 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | S - Sale+OE | $368.70 | -57.3K | 115.9K | -33% | -$21.13M |
| D | 2024-11-08 | 2024-11-07 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | M - OptEx | $93.06 | +156.9K | 256.9K | +157% | +$14.60M |
| D | 2024-11-08 | 2024-11-07 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | F - Tax | $369.02 | -99.6K | 157.3K | -39% | -$36.75M |
| 2024-10-25 | 2024-10-23 | PH | Parker Hannifin | Lobo Kevin | Dir | A - Grant | $0.00 | +299 | 11.1K | +3% | $0 | |
| D | 2024-03-25 | 2024-03-21 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | M - OptEx | $0.00 | +905 | 119.7K | +0.8% | $0 |
| D | 2024-03-25 | 2024-03-21 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | F - Tax | $353.19 | -19.8K | 99.9K | -17% | -$6.99M |
| 2024-03-13 | 2024-03-11 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | A - Grant | $0.00 | +37.8K | 118.8K | +47% | $0 | |
| D | 2023-11-21 | 2023-11-17 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | F - Tax | $291.55 | -103.7K | 137.5K | -43% | -$30.24M |
| DM | 2023-11-21 | 2023-11-17 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | S - Sale+OE | $287.91 | -56.5K | 89.6K | -39% | -$16.26M |
| D | 2023-11-21 | 2023-11-17 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | M - OptEx | $81.14 | +160.2K | 241.2K | +198% | +$13.00M |
| 2023-10-27 | 2023-10-25 | PH | Parker Hannifin | Lobo Kevin | Dir | A - Grant | $0.00 | +453 | 10.8K | +4% | $0 | |
| A | 2023-06-15 | 2023-06-09 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | G - Gift | $0.00 | -8,904 | 81.0K | -10% | $0 |
| 2023-06-13 | 2023-06-05 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | G - Gift | $0.00 | -8,904 | 81.0K | -10% | $0 | |
| D | 2023-03-23 | 2023-03-21 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | F - Tax | $276.83 | -9,425 | 89.8K | -9% | -$2.61M |
| D | 2023-03-23 | 2023-03-21 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | M - OptEx | $0.00 | +504 | 99.3K | +0.5% | $0 |
| 2023-03-09 | 2023-03-07 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | A - Grant | $0.00 | +18.0K | 98.7K | +22% | $0 | |
| DM | 2022-12-05 | 2022-12-02 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | S - Sale+OE | $239.68 | -67.2K | 80.8K | -45% | -$16.11M |
| D | 2022-12-05 | 2022-12-02 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | F - Tax | $240.77 | -120.2K | 148.0K | -45% | -$28.95M |
| D | 2022-12-05 | 2022-12-02 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | M - OptEx | $64.01 | +187.5K | 268.2K | +232% | +$12.00M |
| 2022-10-28 | 2022-10-26 | PH | Parker Hannifin | Lobo Kevin | Dir | A - Grant | $0.00 | +653 | 10.3K | +7% | $0 | |
| D | 2022-03-23 | 2022-03-21 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | M - OptEx | $0.00 | +33.9K | 98.0K | +53% | $0 |
| D | 2022-03-23 | 2022-03-21 | SYK | Stryker Corporation | Lobo Kevin | COB, CEO, Dir | F - Tax | $267.34 | -17.3K | 80.6K | -18% | -$4.63M |
| 2021-10-29 | 2021-10-27 | PH | Parker Hannifin | Lobo Kevin | Dir | A - Grant | $0.00 | +556 | 9,648 | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations